Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

DOT aim to meet  research needs. Visit numerous concurrent sessions for informative presentations, lively dialogue, and meaningful connections with peers. Customize  experience further through focused short courses and a training seminar, interactive group discussions, and networking options that help us engage with experts and solutions providers.

DOT20thAnniversaryeventbrings back popular topics like immunomodulation, protein degraders, and RNA, plus new, expanded, or returning programming on transcription factors, small molecules for cancer targets, and kinases.